These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 35292220

  • 1. Lid wiper epitheliopathy in patients with blepharospasm and/or hemifacial spasm.
    Romero-Caballero MD, Salmerón Ato MP, Palazón-Cabanes A, Caravaca-Alegría A.
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Jul; 97(7):376-380. PubMed ID: 35292220
    [Abstract] [Full Text] [Related]

  • 2. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
    Bayraktar Bilen N, Bilen Ş, Topçu Yılmaz P, Evren Kemer Ö.
    Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
    [Abstract] [Full Text] [Related]

  • 3. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O.
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [Abstract] [Full Text] [Related]

  • 4. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
    Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP.
    Arq Bras Oftalmol; 2006 Aug; 69(1):23-6. PubMed ID: 16491229
    [Abstract] [Full Text] [Related]

  • 5. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
    Quagliato EM, Carelli EF, Viana MA.
    Clin Neuropharmacol; 2010 Aug; 33(1):27-31. PubMed ID: 20124784
    [Abstract] [Full Text] [Related]

  • 6. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
    Kilduff CL, Casswell EJ, Salam T, Hersh D, Ortiz-Perez S, Ezra D.
    JAMA Ophthalmol; 2016 Nov 01; 134(11):1247-1252. PubMed ID: 27606483
    [Abstract] [Full Text] [Related]

  • 7. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P, Chaudhary M, Agrawal JP, Shah DN.
    Kathmandu Univ Med J (KUMJ); 2010 Nov 01; 8(31):305-10. PubMed ID: 22610735
    [Abstract] [Full Text] [Related]

  • 8. [Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm].
    Lasalvia CG, Pereira Lde S, da Cunha MC, Kitadai SP.
    Arq Bras Oftalmol; 2006 Nov 01; 69(5):701-5. PubMed ID: 17187139
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH, Cetinkaya A, Kulwin DR.
    Clin Exp Ophthalmol; 2014 Apr 01; 42(3):254-61. PubMed ID: 23844601
    [Abstract] [Full Text] [Related]

  • 10. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB, Tsai CP, Liao KK, Kao KP, Yuan CL, Yen DJ, Lin KP.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan 01; 62(1):1-5. PubMed ID: 10063705
    [Abstract] [Full Text] [Related]

  • 11. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S.
    Arq Bras Oftalmol; 2006 Jan 01; 69(3):319-22. PubMed ID: 16936952
    [Abstract] [Full Text] [Related]

  • 12. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC, Oliveira GC, Cariello AJ, Felberg S, Osaki MH.
    Arq Bras Oftalmol; 2010 Jan 01; 73(5):405-8. PubMed ID: 21225122
    [Abstract] [Full Text] [Related]

  • 13. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA.
    Eye (Lond); 2000 Jun 01; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
    Li XH, Lin SC, Hu YF, Liu LY, Liu JB, Hong YC.
    Eye Sci; 2012 Dec 01; 27(4):178-81. PubMed ID: 23225838
    [Abstract] [Full Text] [Related]

  • 15. Pain relief in patients receiving periocular botulinum toxin A.
    Harrison AR, Erickson JP, Anderson JS, Lee MS.
    Ophthalmic Plast Reconstr Surg; 2008 Dec 01; 24(2):113-6. PubMed ID: 18356715
    [Abstract] [Full Text] [Related]

  • 16. Five-Year Retrospective Review of Cases with Benign Essential Blepharospasm and Hemifacial Spasm Presenting in a Tertiary Eye Care Center in North India.
    Raj A, Arya SK, Deswal J, Bamotra RK.
    Semin Ophthalmol; 2017 Dec 01; 32(3):371-376. PubMed ID: 27078720
    [Abstract] [Full Text] [Related]

  • 17. Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
    Park YC, Lim JK, Lee DK, Yi SD.
    J Korean Med Sci; 1993 Oct 01; 8(5):334-40. PubMed ID: 8305141
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.
    Jost WH, Kohl A.
    J Neurol; 2001 Apr 01; 248 Suppl 1():21-4. PubMed ID: 11357234
    [Abstract] [Full Text] [Related]

  • 19. Effects of the periocular botulinum toxin on the ocular surface and anterior chamber: a prospective study in patients with hemifacial spasm and blepharospasm.
    Romero-Caballero MD, Miralles de Imperial-Ollero JA, Sarabia-Marín E, Villegas-Pérez MP.
    Int Ophthalmol; 2023 Aug 01; 43(8):2731-2736. PubMed ID: 37185774
    [Abstract] [Full Text] [Related]

  • 20. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
    Pellegrini M, Schiavi C, Taroni L, Sebastiani S, Bernabei F, Roda M, Moscardelli F, Giannaccare G.
    Indian J Ophthalmol; 2019 Sep 01; 67(9):1405-1409. PubMed ID: 31436182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.